Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cigarette Smoke Exposure and Inflammatory Signaling Increase the Expression of the SARS-CoV-2 Receptor ACE2 in the Respiratory Tract
Joan C. Smith, Erin L. Sausville, Vishruth Girish, et al.
Developmental Cell (2020) Vol. 53, Iss. 5, pp. 514-529.e3
Open Access | Times Cited: 397

Showing 1-25 of 397 citing articles:

Mechanisms of SARS-CoV-2 entry into cells
Cody B. Jackson, Michael Farzan, Bing Chen, et al.
Nature Reviews Molecular Cell Biology (2021) Vol. 23, Iss. 1, pp. 3-20
Open Access | Times Cited: 2532
Mechanisms of SARS-CoV-2 Transmission and Pathogenesis
Andrew G. Harrison, Lin Tao, Penghua Wang
Trends in Immunology (2020) Vol. 41, Iss. 12, pp. 1100-1115
Open Access | Times Cited: 1119
Why does COVID-19 disproportionately affect older people?
Amber L. Mueller, Maeve S. McNamara, David Sinclair
Aging (2020) Vol. 12, Iss. 10, pp. 9959-9981
Open Access | Times Cited: 986
Immune determinants of COVID-19 disease presentation and severity
Petter Brodin
Nature Medicine (2021) Vol. 27, Iss. 1, pp. 28-33
Closed Access | Times Cited: 637
Mental health and clinical psychological science in the time of COVID-19: Challenges, opportunities, and a call to action.
June Gruber, Mitchell J. Prinstein, Lee Anna Clark, et al.
American Psychologist (2020) Vol. 76, Iss. 3, pp. 409-426
Open Access | Times Cited: 623
Genome-wide CRISPR Screens Reveal Host Factors Critical for SARS-CoV-2 Infection
Jin Wei, Mia Madel Alfajaro, Peter C. DeWeirdt, et al.
Cell (2020) Vol. 184, Iss. 1, pp. 76-91.e13
Open Access | Times Cited: 512
The effect of smoking on COVID‐19 severity: A systematic review and meta‐analysis
Rohin K. Reddy, Walton N. Charles, Alexandros Sklavounos, et al.
Journal of Medical Virology (2020) Vol. 93, Iss. 2, pp. 1045-1056
Open Access | Times Cited: 443
ACE2: The Major Cell Entry Receptor for SARS-CoV-2
Filippo Scialò, Aurora Daniele, Felice Amato, et al.
Lung (2020) Vol. 198, Iss. 6, pp. 867-877
Open Access | Times Cited: 443
Clinical and Chest Radiography Features Determine Patient Outcomes in Young and Middle-aged Adults with COVID-19
Danielle Toussie, Nicholas Voutsinas, Mark Finkelstein, et al.
Radiology (2020) Vol. 297, Iss. 1, pp. E197-E206
Open Access | Times Cited: 335
COVID-19 and addiction
Mahua Jana Dubey, Ritwik Ghosh, Subham Chatterjee, et al.
Diabetes & Metabolic Syndrome Clinical Research & Reviews (2020) Vol. 14, Iss. 5, pp. 817-823
Open Access | Times Cited: 335
Camostat mesylate inhibits SARS-CoV-2 activation by TMPRSS2-related proteases and its metabolite GBPA exerts antiviral activity
Markus Hoffmann, Heike Hofmann-Winkler, Joan C. Smith, et al.
EBioMedicine (2021) Vol. 65, pp. 103255-103255
Open Access | Times Cited: 329
ACE2: Evidence of role as entry receptor for SARS-CoV-2 and implications in comorbidities
Natalia Zamorano Cuervo, Nathalie Grandvaux
eLife (2020) Vol. 9
Open Access | Times Cited: 322
IL-6: Relevance for immunopathology of SARS-CoV-2
Ekaterina O. Gubernatorova, Е. А. Горшкова, Almina I. Polinova, et al.
Cytokine & Growth Factor Reviews (2020) Vol. 53, pp. 13-24
Open Access | Times Cited: 316
Single-cell meta-analysis of SARS-CoV-2 entry genes across tissues and demographics
Christoph Muus, Malte D. Luecken, Gökcen Eraslan, et al.
Nature Medicine (2021) Vol. 27, Iss. 3, pp. 546-559
Open Access | Times Cited: 314
COVID-19 and Cancer: Current Challenges and Perspectives
Ziad Bakouny, Jessica E. Hawley, Toni K. Choueiri, et al.
Cancer Cell (2020) Vol. 38, Iss. 5, pp. 629-646
Open Access | Times Cited: 262
Single-cell longitudinal analysis of SARS-CoV-2 infection in human airway epithelium identifies target cells, alterations in gene expression, and cell state changes
Neal G. Ravindra, Mia Madel Alfajaro, Victor Gasque, et al.
PLoS Biology (2021) Vol. 19, Iss. 3, pp. e3001143-e3001143
Open Access | Times Cited: 247
ACE2/ADAM17/TMPRSS2 Interplay May Be the Main Risk Factor for COVID-19
Donato Zipeto, Julys da Fonseca Palmeira, Gustavo Adolfo Arganãraz, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 244
Critical Determinants of Cytokine Storm and Type I Interferon Response in COVID-19 Pathogenesis
Santhamani Ramasamy, Selvakumar Subbian
Clinical Microbiology Reviews (2021) Vol. 34, Iss. 3
Open Access | Times Cited: 239
On the whereabouts of SARS-CoV-2 in the human body: A systematic review
Wim Trypsteen, Jolien Van Cleemput, Willem van Snippenberg, et al.
PLoS Pathogens (2020) Vol. 16, Iss. 10, pp. e1009037-e1009037
Open Access | Times Cited: 214
Underlying respiratory diseases, specifically COPD, and smoking are associated with severe COVID-19 outcomes: A systematic review and meta-analysis
Diana C. Sanchez‐Ramirez, Denise Mackey
Respiratory Medicine (2020) Vol. 171, pp. 106096-106096
Open Access | Times Cited: 190
Animal and translational models of SARS-CoV-2 infection and COVID-19
Matt D. Johansen, Aaron T. Irving, Xavier Montagutelli, et al.
Mucosal Immunology (2020) Vol. 13, Iss. 6, pp. 877-891
Open Access | Times Cited: 178
Increasing host cellular receptor—angiotensin‐converting enzyme 2 expression by coronavirus may facilitate 2019‐nCoV (or SARS‐CoV‐2) infection
Meng‐Wei Zhuang, Yun Cheng, Jing Zhang, et al.
Journal of Medical Virology (2020) Vol. 92, Iss. 11, pp. 2693-2701
Open Access | Times Cited: 177
Heterogeneous expression of the SARS-Coronavirus-2 receptor ACE2 in the human respiratory tract
Miguel Ortiz, Andrew L. Thurman, Alejandro A. Pezzulo, et al.
EBioMedicine (2020) Vol. 60, pp. 102976-102976
Open Access | Times Cited: 176
Antiviral Activity of Type I, II, and III Interferons Counterbalances ACE2 Inducibility and Restricts SARS-CoV-2
Idoia Busnadiego, Sonja Fernbach, Marie O. Pohl, et al.
mBio (2020) Vol. 11, Iss. 5
Open Access | Times Cited: 167
Neuropathology of COVID-19 (neuro-COVID): clinicopathological update.
Jerry J. Lou, Mehrnaz Movassaghi, Dominique Gordy, et al.
DOAJ (DOAJ: Directory of Open Access Journals) (2021) Vol. 2, pp. 2-2
Closed Access | Times Cited: 112
Page 1 - Next Page

Scroll to top